The CATALIS Initiative

Launched in 2017 with the financial support of Quebec’s ministère de l’Économie, de l’Innovation et de l’Énergie and the mobilization of several public and private partners, CATALIS’ governmental mandate is to increase the number of clinical trials conducted by companies in Quebec, facilitate collaboration between the life sciences sector’s various stakeholders, and accelerate the development of innovative treatments.

The Quebec Advantage

The world’s major pharmaceutical companies have chosen to conduct clinical trials in Quebec because of its medical and scientific research expertise, cutting-edge infrastructure and clinical research-friendly economic and regulatory environment.

The Quebec Advantage

5 reasons to carry out clinical trials in Quebec

Stay in touch

To find out more about clinical research in Quebec and to follow the progress of our projects, sign up for our newsletter.

Sign me up for the newsletter

A solid partnership

Underpinning the Initiative is a partnership consisting of five health and social service organizations from Quebec and eight pharmaceutical companies.

CATALIS Quebec acts as a coordination office by rallying behind the efforts of its partners in order to stimulate private investment and promote excellence in the conduct of phase 1, 2 and 3 clinical trials.

Our projects benefit all life science research stakeholders and have positive economic and social impacts for Quebec and Canada.

Discover our partners